PIK3CA mutations in patients with advanced cancers treated in a phase I clinic

被引：0
|
作者：
Janku, F.
Hong, D. S.
Tsimberidou, A. M.
Naing, A.
Falchook, G. S.
Wheler, J. J.
Moulder, S. L.
Kurzrock, R.
机构：
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(09)72172-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] PIK3CA mutations in glioblastoma multiforme
    Hartmann, C
    Bartels, G
    Gehlhaar, C
    Holtkamp, N
    von Deimling, A
    ACTA NEUROPATHOLOGICA, 2005, 109 (06) : 639 - 642
  • [32] PHASE II BASKET TRIAL OF PERIFOSINE MONOTHERAPY IN PATIENTS WITH METASTATIC OR RECURRENT GYNECOLOGIC CANCERS WITH OR WITHOUT PIK3CA MUTATIONS
    Kagabu, M.
    Hasegawa, K.
    Mizuno, M.
    Oda, K.
    Aoki, D.
    Mabuchi, S.
    Kamiura, S.
    Yamaguchi, S.
    Aoki, Y.
    Saito, T.
    Yunokawa, M.
    Takehara, K.
    Okamoto, A.
    Ochiai, K.
    Kimura, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 869 - 870
  • [33] PIK3CA mutations in nasopharyngeal carcinoma
    Or, YYY
    Hui, ABY
    To, KF
    Lam, CNY
    Lo, KW
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 1065 - 1067
  • [34] Somatic PIK3CA Mutations in Seven Patients with PIK3CA-Related Overgrowth Spectrum
    Yeung, Kit San
    Ip, Janice Jing Kun
    Chow, Chin Pang
    Kuong, Evelyn Yue Ling
    Tam, Paul Kwong-Hang
    Chan, Godfrey Chi-Fung
    Chung, Brian Hon-Yin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (04) : 978 - 984
  • [35] Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial
    Heilig, C. E.
    Teleanu, M-V.
    Desuki, A.
    Kindler, T.
    Deschler, B.
    Kunzmann, V.
    von Bubnoff, N.
    Illert, L.
    Rieke, D. T.
    Suesse, H.
    Heiligenthal, L.
    Kreutzfeldt, S.
    Horak, P.
    Steindorf, K.
    Benner, A.
    Huebschmann, D.
    Schweigert, N.
    Glimm, H.
    Froehling, S.
    Schlenk, R. F.
    ANNALS OF ONCOLOGY, 2024, 35 : S295 - S296
  • [36] Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
    J Abubaker
    P Bavi
    S Al-Harbi
    M Ibrahim
    A K Siraj
    N Al-Sanea
    A Abduljabbar
    L H Ashari
    S Alhomoud
    F Al-Dayel
    S Uddin
    K S Al-Kuraya
    Oncogene, 2008, 27 : 3539 - 3545
  • [37] PIK3CA mutations in plasma cell-free DNA predict survival and treatment outcomes in patients with advanced cancers.
    Dumbrava, Ecaterina E. Ileana
    Huang, Helen J.
    Stuckett, Ana
    Madwani, Kiran
    Adat, Abha
    Hong, David S.
    Piha-Paul, Sarina A.
    Subbiah, Vivek
    Karp, Daniel D.
    Fu, Siqing
    Naing, Aung
    Tsimberidou, Apostolia M.
    Moulder, Stacey
    Koenig, Kimberly
    Barcenas, Carlos H.
    Kee, Bryan
    Fogelman, David
    Kopetz, Scott
    Meric-Bernstam, Funda
    Janku, Filip
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 28 - 29
  • [38] Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
    Abubaker, Jehad
    Bavi, Prashant
    Al-Harbi, Sayer
    Ibrahim, Muna
    Ai-Sanea, Nasser
    Jabbar, Alaa Abdul
    Ashari, Luai
    Alhomoud, Samar
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3486S - 3487S
  • [39] Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
    Abubaker, J.
    Bavi, P.
    Al-Harbi, S.
    Ibrahim, M.
    Siraj, A. K.
    Al-Sanea, N.
    Abduljabbar, A.
    Ashari, L. H.
    Alhomoud, S.
    Al-Dayel, F.
    Uddin, S.
    Al-Kuraya, K. S.
    ONCOGENE, 2008, 27 (25) : 3539 - 3545
  • [40] PIK3CA gene mutations in breast carcinoma in Malaysian patients
    Leong, Vincent Ching-Shian
    Jabal, Mohd Faizal
    Leong, Pooi Pooi
    Abdullah, Maizaton Atmadini
    Gul, Yunus Alif
    Seow, Heng Fong
    CANCER GENETICS AND CYTOGENETICS, 2008, 187 (02) : 74 - 79
12345